End-of-day quote
Taiwan S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
27.8
TWD
|
+0.36%
|
|
+1.28%
|
-3.81%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,472
|
2,452
|
2,901
|
2,967
|
2,967
|
2,916
|
Enterprise Value (EV)
1 |
2,216
|
2,322
|
2,709
|
2,914
|
2,917
|
2,522
|
P/E ratio
|
20.9
x
|
27.9
x
|
27.9
x
|
29.1
x
|
18.5
x
|
19.3
x
|
Yield
|
2.65%
|
1.85%
|
1.91%
|
1.87%
|
2.89%
|
-
|
Capitalization / Revenue
|
1.17
x
|
1.2
x
|
1.45
x
|
1.25
x
|
1.11
x
|
1.1
x
|
EV / Revenue
|
1.05
x
|
1.14
x
|
1.35
x
|
1.23
x
|
1.1
x
|
0.95
x
|
EV / EBITDA
|
11.5
x
|
11.3
x
|
15.4
x
|
14.9
x
|
10.6
x
|
8.85
x
|
EV / FCF
|
-24.6
x
|
19
x
|
15
x
|
-25.7
x
|
-70.6
x
|
6.64
x
|
FCF Yield
|
-4.06%
|
5.27%
|
6.68%
|
-3.89%
|
-1.42%
|
15.1%
|
Price to Book
|
1.22
x
|
1.21
x
|
1.38
x
|
1.44
x
|
1.34
x
|
1.25
x
|
Nbr of stocks (in thousands)
|
100,912
|
100,912
|
100,912
|
100,912
|
100,912
|
100,912
|
Reference price
2 |
24.50
|
24.30
|
28.75
|
29.40
|
29.40
|
28.90
|
Announcement Date
|
3/29/19
|
3/31/20
|
3/31/21
|
3/31/22
|
3/31/23
|
3/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,106
|
2,036
|
2,004
|
2,374
|
2,664
|
2,647
|
EBITDA
1 |
193.1
|
205.8
|
175.8
|
195.5
|
275.6
|
284.8
|
EBIT
1 |
136.8
|
128.8
|
98.94
|
104.3
|
184.9
|
194.2
|
Operating Margin
|
6.5%
|
6.32%
|
4.94%
|
4.39%
|
6.94%
|
7.34%
|
Earnings before Tax (EBT)
1 |
150.3
|
128.4
|
124.8
|
138.1
|
200.5
|
209.9
|
Net income
1 |
108.4
|
87.92
|
104.6
|
102.2
|
161.4
|
152.2
|
Net margin
|
5.15%
|
4.32%
|
5.22%
|
4.31%
|
6.06%
|
5.75%
|
EPS
2 |
1.174
|
0.8700
|
1.030
|
1.010
|
1.590
|
1.500
|
Free Cash Flow
1 |
-89.94
|
122.4
|
181
|
-113.3
|
-41.3
|
379.5
|
FCF margin
|
-4.27%
|
6.01%
|
9.03%
|
-4.77%
|
-1.55%
|
14.34%
|
FCF Conversion (EBITDA)
|
-
|
59.49%
|
102.96%
|
-
|
-
|
133.23%
|
FCF Conversion (Net income)
|
-
|
139.25%
|
173.04%
|
-
|
-
|
249.39%
|
Dividend per Share
2 |
0.6500
|
0.4500
|
0.5500
|
0.5500
|
0.8500
|
-
|
Announcement Date
|
3/29/19
|
3/31/20
|
3/31/21
|
3/31/22
|
3/31/23
|
3/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
256
|
130
|
192
|
52.8
|
50
|
395
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-89.9
|
122
|
181
|
-113
|
-41.3
|
380
|
ROE (net income / shareholders' equity)
|
6.02%
|
4.38%
|
5.1%
|
4.96%
|
7.55%
|
6.7%
|
ROA (Net income/ Total Assets)
|
2.99%
|
2.61%
|
2.04%
|
2.11%
|
3.65%
|
3.77%
|
Assets
1 |
3,632
|
3,368
|
5,131
|
4,851
|
4,425
|
4,032
|
Book Value Per Share
2 |
20.00
|
20.10
|
20.80
|
20.40
|
22.00
|
23.10
|
Cash Flow per Share
2 |
4.430
|
4.160
|
4.660
|
4.890
|
4.410
|
6.430
|
Capex
1 |
171
|
30.9
|
46.3
|
46.7
|
45
|
28.8
|
Capex / Sales
|
8.12%
|
1.52%
|
2.31%
|
1.97%
|
1.69%
|
1.09%
|
Announcement Date
|
3/29/19
|
3/31/20
|
3/31/21
|
3/31/22
|
3/31/23
|
3/15/24
|
|
1st Jan change
|
Capi.
|
---|
| -3.81% | 86M | | -3.41% | 9.4B | | -3.90% | 1.39B | | -7.38% | 1.18B | | -18.42% | 856M | | +0.48% | 470M | | +3.62% | 437M | | -49.68% | 360M | | -24.72% | 333M | | -2.42% | 212M |
Medical Equipment Wholesale
|